Literature DB >> 7472816

Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee.

D S Borowitz1, R J Grand, P R Durie.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7472816     DOI： 10.1016/s0022-3476(95)70153-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  37 in total

Review 1.  Cystic fibrosis colonopathy.

Authors:  J D Lloyd-Still; D W Beno; R M Kimura
Journal:  Curr Gastroenterol Rep       Date:  1999-06

Review 2.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

3.  Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls.

Authors:  H P Haber; N Benda; G Fitzke; A Lang; M Langenberg; J Riethmüller; M Stern
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

Review 4.  Patterns of GI disease in adulthood associated with mutations in the CFTR gene.

Authors:  Michael Wilschanski; Peter R Durie
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

5.  Relation between dietary intake and nutritional status in cystic fibrosis.

Authors:  H Anthony; J Bines; P Phelan; S Paxton
Journal:  Arch Dis Child       Date:  1998-05       Impact factor: 3.791

Review 6.  Uses and abuses of enzyme therapy in cystic fibrosis.

Authors:  P Durie; D Kalnins; L Ellis
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

7.  Is fibrosing colonopathy an immune mediated disease?

Authors:  J Lee; W Ip; P Durie
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

8.  Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.

Authors:  Gavin R Graff; John McNamara; James Royall; Steven Caras; Kristin Forssmann
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

9.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

10.  Indomethacin and pancreatic enzymes synergistically damage intestine of rats.

Authors:  R E Kimura; V Arango; J Lloyd-Still
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.